Literature DB >> 12115277

Serpens endocrania symmetrica (SES): a new term and a possible clue for identifying intrathoracic disease in skeletal populations.

Israel Hershkovitz1, Charles M Greenwald, Bruce Latimer, Lyman M Jellema, Susanne Wish-Baratz, Vered Eshed, Olivier Dutour, Bruce M Rothschild.   

Abstract

This paper describes a phenomenon in the endocranial plate, which we have termed "serpens endocrania symmetrica" (SES), and discusses its value as a diagnostic tool. The affected discolored bone area exhibits disruption of the endocranial surface, lending it a maze-like appearance. Histological sections demonstrate that the process is limited to the most superficial portion of the endocranium, with no diploic and ectocranial involvement (sinus areas excepted). Adult skulls (n = 1,884) from the Hamann-Todd collection (HTH), housed at the Cleveland Museum of Natural History, were utilized for the present study. SES was recognized in 32 of the 1,884 skulls studied (1.7%). The frequency of SES among individuals reported to have died from tuberculosis (TB) was 4.4%. The rate of SES in the non-TB sample was only 0.53%. The locations were as follows: limited to sinus area, 28.1%; calvarium (excluding the sinuses), 46.9%; sinus + calvarium, 25.0%. SES was bilateral in 90.9% of cases. Twenty-five of the 32 individuals (78.1%) with SES in the HTH collection had tuberculosis specifically listed as the cause of death. Six of the other 7 individuals had infections other than TB. In 29 of the 32 individuals with SES, infection involved structures within the thorax. As SES was also associated with another osteological phenomenon known to represent pulmonary disease, i.e., hypertrophic osteoarthropathy (HOA; 68.0% of SES individuals also had HOA), SES may be of diagnostic value in paleopathology for the recognition of intrathoracic disease, and perhaps tuberculosis. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2002        PMID: 12115277     DOI: 10.1002/ajpa.10077

Source DB:  PubMed          Journal:  Am J Phys Anthropol        ISSN: 0002-9483            Impact factor:   2.868


  6 in total

1.  Cribra orbitalia is a vascular phenomenon unrelated to marrow hyperplasia or anemia: Paradigm shift for cribra orbitalia.

Authors:  Bruce M Rothschild; Matthew J Zdilla; Lyman M Jellema; H Wayne Lambert
Journal:  Anat Rec (Hoboken)       Date:  2020-11-09       Impact factor: 2.227

2.  Evidence of infectious disease, trauma, disability and deficiency in skeletons from the 19th/20th century correctional facility and asylum «Realta» in Cazis, Switzerland.

Authors:  Christine Cooper; Bernd Heinzle; Thomas Reitmaier
Journal:  PLoS One       Date:  2019-05-08       Impact factor: 3.240

3.  Tracking down the White Plague. Chapter three: Revision of endocranial abnormally pronounced digital impressions as paleopathological diagnostic criteria for tuberculous meningitis.

Authors:  Olga Spekker; David R Hunt; William Berthon; László Paja; Erika Molnár; György Pálfi; Michael Schultz
Journal:  PLoS One       Date:  2021-03-19       Impact factor: 3.240

4.  Detection and molecular characterization of 9,000-year-old Mycobacterium tuberculosis from a Neolithic settlement in the Eastern Mediterranean.

Authors:  Israel Hershkovitz; Helen D Donoghue; David E Minnikin; Gurdyal S Besra; Oona Y-C Lee; Angela M Gernaey; Ehud Galili; Vered Eshed; Charles L Greenblatt; Eshetu Lemma; Gila Kahila Bar-Gal; Mark Spigelman
Journal:  PLoS One       Date:  2008-10-15       Impact factor: 3.240

5.  Possible cases of leprosy from the Late Copper Age (3780-3650 cal BC) in Hungary.

Authors:  Kitti Köhler; Antónia Marcsik; Péter Zádori; Gergely Biro; Tamás Szeniczey; Szilvia Fábián; Gábor Serlegi; Tibor Marton; Helen D Donoghue; Tamás Hajdu
Journal:  PLoS One       Date:  2017-10-12       Impact factor: 3.240

6.  Tracking down the White Plague: The skeletal evidence of tuberculous meningitis in the Robert J. Terry Anatomical Skeletal Collection.

Authors:  Olga Spekker; David R Hunt; László Paja; Erika Molnár; György Pálfi; Michael Schultz
Journal:  PLoS One       Date:  2020-03-18       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.